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Disagreement in cardiac output
measurements between fourth-generation
FloTrac and critical care ultrasonography in
patients with circulatory shock: a
prospective observational study
Thomas Kaufmann1* , Ramon P. Clement1, Bart Hiemstra1,2 , Jaap Jan Vos1 , Thomas W. L. Scheeren1 ,
Frederik Keus2, Iwan C. C. van der Horst2 and SICS Study Group
Abstract
Background: Cardiac output measurements may inform diagnosis and provide guidance of therapeutic
interventions in patients with hemodynamic instability. The FloTrac™ algorithm uses uncalibrated arterial pressure
waveform analysis to estimate cardiac output. Recently, a new version of the algorithm has been developed. The
aim was to assess the agreement between FloTrac™ and routinely performed cardiac output measurements
obtained by critical care ultrasonography in patients with circulatory shock.
Methods: A prospective observational study was performed in a tertiary hospital from June 2016 to January 2017.
Adult critically ill patients with circulatory shock were eligible for inclusion. Cardiac output was measured
simultaneously using FloTrac™ with a fourth-generation algorithm (COAP) and critical care ultrasonography (COCCUS).
The strength of linear correlation of both methods was determined by the Pearson coefficient. Bland-Altman plot
and four-quadrant plot were used to track agreement and trending ability.
Result: Eighty-nine paired cardiac output measurements were performed in 17 patients during their first 24 h of
admittance. COAP and COCCUS had strong positive linear correlation (r
2 = 0.60, p < 0.001). Bias of COAP and COCCUS
was 0.2 L min−1 (95% CI − 0.2 to 0.6) with limits of agreement of − 3.6 L min−1 (95% CI − 4.3 to − 2.9) to 4.0 L min−1
(95% CI 3.3 to 4.7). The percentage error was 65.6% (95% CI 53.2 to 77.3). Concordance rate was 64.4%.
Conclusions: In critically ill patients with circulatory shock, there was disagreement and clinically unacceptable
trending ability between values of cardiac output obtained by uncalibrated arterial pressure waveform analysis and
critical care ultrasonography.
Trial registration: Clinicaltrials.gov, NCT02912624, registered on September 23, 2016
Keywords: Cardiac output, Critical care ultrasonography, Intensive care, Critically ill, Shock, Monitoring, Pulse
contour analysis
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Background
Critically ill patients with circulatory shock have in-
creased risks of multi-organ failure, long-term morbidity,
and mortality [1]. Advanced hemodynamic monitoring
in these patients may inform diagnosis and simultan-
eously guide management by providing insight into car-
diac function, cardiac preload, and afterload [2]. Several
methods for measuring cardiac output (CO) exist, vary-
ing from invasive (e.g. thermodilution by pulmonary
artery catheter (PAC)) to minimally invasive (e.g. pulse
contour analysis by FloTrac™ (Edwards Lifesciences,
Irvine, USA)) or even non-invasive (e.g. transthoracic
Doppler ultrasound by critical care ultrasonography
(CCUS)). These methods all have their own merits, dis-
advantages and requirements [3].
One type of pulse contour analysis is the uncalibrated
arterial pressure waveform analysis method to estimate
CO (APCO). Reliability of APCO is questioned in pa-
tients with hemodynamic instability, and this occurs fre-
quently in patients admitted to the ICU [4]. Therefore,
CO measurements obtained by APCO should be inter-
preted with caution in critically ill patients with circula-
tory shock [5, 6].
The FloTrac™ system using the APCO method calcu-
lates CO based on the principle that aortic pulse pres-
sure is proportional to stroke volume (SV) and inversely
related to aortic compliance using a proprietary algo-
rithm. FloTrac™ has been widely studied in more than
70 validation studies as of yet, mostly showing adequate
performance in normo- and hypodynamic conditions,
but not in patients with large changes in vascular tone
which typically occur in patients with circulatory shock
[7]. However, these studies vary by the statistical
methods and versions of the algorithm used. Recently,
the fourth-generation algorithm was developed to im-
prove performance.
Evaluation of the trending ability rather than the
agreement of absolute values of CO monitoring devices
is increasingly considered in validation studies for as-
sessment of potential clinical usefulness [8]. In addition
to one single CO measurement for diagnosing circula-
tory shock, repeated measurements of CO informing the
trending ability could be informative for monitoring and
guidance of supportive treatments of patients with circu-
latory shock.
The aim of our study was to compare both agreements
and trending ability for APCO measurements of CO
(COAP) with CO routinely measured by CCUS (COCCUS)
in critically ill patients with circulatory shock. CCUS
was chosen as the reference standard since it is the pre-
ferred method for diagnosis, but not for monitoring, of
circulatory shock in critically ill patients and is widely
available [2, 9]. Importantly, it should be noted that
CCUS is not a gold standard reference technique for
method comparison studies aiming to evaluate the valid-
ity of CO monitors [10].
Methods
This study was a substudy of the Simple Intensive
Care Studies-I (SICS-I), which was a single-centre,
prospective, observational cohort study in which all
consecutive acutely admitted adult patients expected
to stay beyond 24 h were included (NCT02912624)
[16, 17]. The STROBE guidelines for reporting obser-
vational studies were used (Additional file 1) [11].
The checklist for CO monitor method comparison
studies was used [10]. The local institutional review
board (Medisch Ethische Toetsingscommissie, Univer-
sity Medical Center Groningen) approved the study
(M15.168207 and M16.193856). Written informed
consent was obtained from all patients.
Selection criteria
In this substudy, all consecutive acutely admitted adult pa-
tients with suspected circulatory shock and expected to
stay beyond 48 h were included from June 2016 to January
2017. The circulatory shock was defined as the require-
ment of any dose of vasopressor to maintain a mean arter-
ial pressure (MAP) of 60mmHg or if the MAP remained
below 70mmHg despite fluid resuscitation (defined by at
least 1000mL of crystalloids). In addition, at least one
other sign of organ or tissue hypoperfusion had to be
present: altered state of mind (Alert-Voice-Pain-Unre-
sponsive scale) [12], mottled skin (Mottling score ≥ 1
[13]), decreased urine output (≤ 0.3mL kg−1 h−1) or in-
creased serum lactate level (≥ 2mmol L−1). Exclusion cri-
teria were inability to obtain sufficient quality CCUS
images; no arterial line; atrial fibrillation; and aortic valve
or mitral valve diseases known to impair the arterial wave-
form. We included this group of patients because CO
measurements are indicated to identify the type of shock,
select necessary therapeutic interventions and evaluate pa-
tient’s response to therapy [2].
Objectives
The primary objective was to evaluate COAP measure-
ments in terms of the agreement and trending ability
against COCCUS as reference technique in patients with
circulatory shock.
Definitions and bias
Patient characteristics including clinical, hemodynamic
and laboratory variables as well as Acute Physiology And
Chronic Health Evaluation (APACHE) IV and Simplified
Acute Physiology Score (SAPS) II values were recorded
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[14, 15]. Measurements were performed following proto-
colized definitions and procedures [16, 17].
In short, COCCUS was measured by transthoracic
echocardiography using the Vivid-S6 system (General
Electric, Horton, Norway) with cardiac probe M3S or
M4S, and with default cardiac imaging setting. The para-
sternal long axis was used to measure the left ventricular
outflow tract diameter. In the apical five-chamber view,
a pulse wave Doppler signal in the left ventricular out-
flow tract was used to measure the velocity time integral.
COCCUS was calculated using an established formula
[18]. CCUS was performed after ICU admission within
6 h and repeated once every 24 h after admission pro-
vided there was no interference with clinical care. Re-
searchers were trained in performing CCUS by
experienced cardiologist-intensivists.
The FloTrac™ sensor was connected to an indwelling
radial artery catheter and an EV1000™ monitor (version
4.00; Edwards Lifesciences, Irvine, USA), which continu-
ously displayed COAP values. The value of COAP dis-
played on the EV1000™ monitor was registered
simultaneously (i.e. ‘beat-to-beat’) with each COCCUS
measurement.
All measurements, including CCUS findings, were
kept blind for the caregivers. Quality of CCUS images
and COCCUS measurements were validated by an
independent specialized core laboratory (Groningen
Image Core Lab) blinded for the COAP measurements
Statistical analysis
No formal sample size calculation was performed due
to lack of data on COAP variation in patients with
circulatory shock. Therefore, this study has an ex-
ploratory nature.
Data were presented as means with standard devia-
tions or medians with interquartile ranges depending on
distributions. Normality of data was checked using the
Shapiro-Wilk test. Dichotomous and categorical data
were presented in proportions.
Correlations were assessed by scatter plot, and the
strength of linear correlation was determined by calcu-
lating a Pearson (r) coefficient. Bland-Altman analyses of
repeated measurements in each patient were performed
and means (bias) and SD of the differences, 95% limits
of agreement (LOA) (=mean difference ± 1.96 × SD of
the difference) as well as the percentage error of COAP
versus COCCUS were calculated [19, 20]. To evaluate the
trending ability of COAP versus COCCUS a four-quadrant
plot was used and the concordance rate was calculated
using an exclusion zone of 0.5 Lmin−1 [21]. For statis-
tical analysis, we used STATA version 15.0 (StataCorp,
College Station, USA).
Fig. 1 Patient flowchart. Abbreviations: CCUS, critical care ultrasonography
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Results
Participants
During the study period, 184 patients were diagnosed
with circulatory shock, but only 24 patients appeared eli-
gible for this study. One hundred patients who had cir-
culatory shock were not included as they were expected
to stay for less than 48 h, and 60 patients with circula-
tory shock were not included because CCUS was not
possible or image quality was insufficient to perform
measurements. Six patients had to be excluded because
study procedures interfered with clinical care, leaving 18
patients to be included. One patient was excluded after-
wards for invalid COAP measurements due to improper
use of a FloTrac™ sensor. Thus, 17 patients were in-
cluded in the final analyses (Fig. 1).
Bias, precision and correlation
The characteristics of the 17 included patients are
shown in Table 1 (and Additional file 2: Table S1). The
mean COAP and COCCUS for 89 paired measurements
were 5.9 ± 1.9 Lmin−1 and 5.7 ± 2.0 L min−1, respectively
(p = 0.24). A significant correlation was observed for all
CO measurements (r2 = 0.60, p < 0.001) (Fig. 2). Bias was
0.2 L min−1 (95% CI − 0.2 to 0.6), with LOA of − 3.6 L
min−1 (95% CI − 4.3 to − 2.9) to 4.0 L min−1 (95% CI 3.3
to 4.7) (Fig. 3). Plotting a regression line in the
Bland-Altman plot gave no arguments for proportional
bias (line not shown). The overall percentage error was
65.6% (95% CI 53.2 to 77.3). Individual cardiac output
measurements for each patient are provided in Add-
itional file 3: Table S2.
Trending ability
For assessment of trending ability 72 paired measure-
ments were analysed. Trending of measurements was
evaluated using a four-quadrant plot (Fig. 4). Forty-five
paired measurements showed a clinically relevant
change, which was defined as larger than 0.5 Lmin−1.
The concordance rate was 64.4%.
Discussion
In this prospective observational study, agreement and
trending ability of COAP was compared with COCCUS in
critically ill patients with circulatory shock. COAP
showed a low bias of 0.2 Lmin−1 but a large percentage
error of 65.6% when compared with COCCUS, indicating
disagreement [20]. Trending ability was poor with a con-
cordance rate of 64.4%. The new FloTrac™ algorithm
should not be used for diagnosis or guidance of treat-
ment in critically ill patients with circulatory shock.
Interpretation
There are no data on the reliability of CO measure-
ments with the fourth-generation FloTrac™ software
algorithm in critically ill patients with shock as of yet.
The main concern with the previous version(s) of the
APCO algorithm was the lack of reliability in tracking
CO changes after hemodynamic interventions or in
patients with sepsis [7, 22].
The low bias and the high percentage error of CO
measurements are in accordance with results from an-
other study, which tested the fourth-generation algo
rithm for tracking CO measurements after administra-
tion of phenylephrine to increase vasomotor tone in pa-
tients prior to cardiac surgery (bias − 0.7 Lmin−1;
percentage error 55.4%) [23]. Concordance rate for
trending ability was 87% which was higher than in our
study. In that study, the chosen reference technique for
measuring CO was thermodilution.
In a more recent study in patients undergoing car-
diac surgery, the new FloTrac™ algorithm also showed
lack of agreement and trending ability (bias − 0.4 L
min−1; percentage error 37.1%; concordance rate 76%)
[24]. The reference technique was thermodilution and
Table 1 Patient characteristics
Patient characteristics (n = 17)
Age (years) 65 (9)
Male gender, n (%) 14 (82%)
Body mass index (kg m−2) 25.7 (4.7)
Clinical characteristics on study inclusion
Heart rate (bpm) 95 (26)
Systolic arterial pressure (mmHg) 102 (15)
Diastolic arterial pressure (mmHg) 55 (6)
Mean arterial pressure (mmHg) 69 (7)
Norepinephrine therapy, n (%) 16 (94%)
Norepinephrine dose (μg kg−1 min−1) 0.13 (0.05, 0.38)
Mechanical ventilation, n (%) 12 (71%)
Positive end-expiratory pressure (cm H2O) 8 (6, 9)









Urine output (mL kg−1 h−1) 0.49 (0.26, 0.66)
Lactate (mmol L−1) 1.7 (1.4, 3.4)
APACHE IV—score (points) 92 (32)
SAPS II— (points) 56 (17)
Data are presented as the mean and standard deviation, median and
interquartile ranges or as absolute frequencies with percentages
as appropriate
Abbreviations: AVPU alert, verbal, pain, unresponsive; APACHE Acute Physiology
And Chronic Health Evaluation; SAPS Simplified Acute Physiology Score
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in that study, bias was influenced by systemic
vascular resistance.
Another study tested the fourth-generation FloTrac™
algorithm in patients undergoing abdominal aortic
aneurysm surgery and also found a low bias and high
percentage error (bias 0.4 L min−1; percentage error
46.7%) of CO measurements [25]. The concordance rate
for trending ability was 26.9% before and after aortic
clamping and 47.3% before and after first unclamping of
the iliac artery. The reference technique chosen in this
study was transoesophageal echocardiography.
Advanced hemodynamic monitoring techniques are
currently used to identify the type of shock, to guide
choices of interventions and to evaluate the response
to therapy. Less invasive hemodynamic monitoring
techniques such as APCO are currently not recom-
mended for use in patients with shock, especially
when receiving vasopressors [2, 26]. Our findings sup-
port this statement.
Implications and generalizability
Even though CO monitoring is considered a cornerstone
in diagnosing and managing circulatory shock, the se-
quential evaluation of the hemodynamic state during
shock is only a level 1 recommendation based on low
quality of evidence [2].
The abovementioned studies validating the new
fourth-generation FloTrac™ algorithm were performed in
different target populations and contained different ref-
erence techniques, which limit comparability. There is a
concern about the interchangeability of COCCUS and CO
measurements by thermodilution, and tracking ability of
the two methods has only been scarcely assessed and
needs evaluation by larger studies [27].
Considerations and limitations
There are several considerations and limitations when
interpreting the results of our study. First, since only
parallel and no serial CO measurements were performed
for each time point, the precision of individual measure-
ments could not be assessed. While only few studies de-
termined the precision of the CCUS and FloTrac™
technologies, it is a given that both methods have some
degree of variation which influences precision of agree-
ment [28]. This might influence—and possibly overesti-
mate—the observed bias and precision to an unknown
extent, since the precision of the CCUS as reference
method was not incorporated.
Second, a stepwise approach and checklist for the
complete presentation of CO method comparison re-
search have been published [10]. This checklist includes
a design study phase where it is encouraged that criteria
Fig. 2 Scatter plot of cardiac output measured by FloTrac™ and CCUS. Abbreviations: COAP, cardiac output measured using fourth-generation
FloTrac™ algorithm; COCCUS, cardiac output measured by critical care ultrasonography
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Fig. 4 Four-quadrant plot showing the trend of COAP versus COCCUS. Exclusion zone of 0.5 L min
−1 (white area). Abbreviations: COAP, cardiac
output measured using fourth-generation FloTrac™ algorithm; COCCUS, cardiac output measured by critical care ultrasonography
Fig. 3 Bland-Altman plot for repeated measurements showing the comparison between COAP and COCCUS. The mean bias between COAP and
COCCUS and the upper and lower limits of agreement (LOA) are presented. Abbreviations: COAP, cardiac output measured using fourth-generation
FloTrac™ algorithm; COCCUS, cardiac output measured by critical care ultrasonography
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for acceptable bias and LOA or percentage error are de-
fined, and a sample size calculation should be performed
prior to the conduct of method comparison studies. In
our study, we defined clinically acceptable limits based
on available literature, but we did not specify a sample
size in advance. The current study could serve as a pilot
for a further validation study.
Third, during the study period, we included only 17
patients. Patients with circulatory shock were eligible
only if they were expected to stay for longer than 48 h
and if it was possible to perform CCUS. We chose this
definition to ensure that a complete picture of shock
treatment could be presented which allowed for the best
comparison between the two methods. Last, CCUS was
used as a reference technique in our study despite pul-
monary or transpulmonary thermodilution being the
gold standard for CO method comparison studies [10].
Therefore, we cannot prove direct superiority of either
method. In order to do this, a comparison with a ther-
modilution method will have to be performed. We chose
CCUS as reference because it is currently the first-line
evaluation modality in patients with circulatory shock
and also because it is widely available and used in the
ICU for diagnostic purposes [2, 29]. However, images re-
quired to make COCCUS measurements are unobtainable
in up to 20% of patients [30].
FloTrac™ measurements of CO are still not recom-
mended in critically ill patients [5, 6], and further clinical
studies comparing minimally invasive techniques for CO
estimation with a reference technique are needed for
further validation of these techniques and also for ex-
tending applicability to other types of patients, who were
initially not the target population.
Conclusions
In critically ill patients with circulatory shock, there was
disagreement and clinically unacceptable trending ability
between values of cardiac output obtained by uncali-
brated arterial pressure waveform analysis and critical
care ultrasonography.
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